Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The effect of licorice drink on the systemic exposure of verapamil in rabbits.

Al-Deeb ID, Arafat TA, Irshaid YM.

Drug Metab Lett. 2010 Aug;4(3):173-9.

PMID:
20642450
2.

The effect of ethyl acetate extract of pomelo mix on systemic exposure of verapamil in rabbits.

Aqel SM, Irshaid YM, Gharaibeh MN, Arafat TA.

Drug Metab Lett. 2011 Apr;5(2):92-8.

PMID:
21457137
3.
4.

Effects of grapefruit juice and smoking on verapamil concentrations in steady state.

Fuhr U, Müller-Peltzer H, Kern R, Lopez-Rojas P, Jünemann M, Harder S, Staib AH.

Eur J Clin Pharmacol. 2002 Apr;58(1):45-53. Epub 2002 Mar 15.

PMID:
11956673
5.

Effects of Kampo medicines on P-glycoprotein.

Satoh T, Watanabe Y, Ikarashi N, Ito K, Sugiyama K.

Biol Pharm Bull. 2009 Dec;32(12):2018-21.

6.

The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.

Dadashzadeh S, Javadian B, Sadeghian S.

Biopharm Drug Dispos. 2006 Oct;27(7):329-34.

PMID:
16892180
8.

Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit.

De Cicco M, Macor F, Robieux I, Zanette G, Fantin D, Fabiani F, Nicolosi G, Fracasso A, Toffoli G, Santantonio C, Lestuzzi C, Matovic M, Boiocchi M.

Crit Care Med. 1999 Feb;27(2):332-9.

PMID:
10075058
9.

Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.

Hong SP, Chang KS, Koh YY, Choi DH, Choi JS.

Arch Pharm Res. 2009 Oct;32(10):1447-52. doi: 10.1007/s12272-009-2015-2. Epub 2009 Nov 8.

PMID:
19898809
11.

Effect of verapamil on the pharmacokinetics of aliskiren in healthy participants.

Rebello S, Leon S, Hariry S, Dahlke M, Jarugula V.

J Clin Pharmacol. 2011 Feb;51(2):218-28. doi: 10.1177/0091270010365717. Epub 2010 Apr 22.

PMID:
20413453
12.

Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.

Hu N, Xie S, Liu L, Wang X, Pan X, Chen G, Zhang L, Liu H, Liu X, Liu X, Xie L, Wang G.

Drug Metab Dispos. 2011 Mar;39(3):419-25. doi: 10.1124/dmd.110.035642. Epub 2010 Dec 6.

13.

Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.

Piao YJ, Choi JS.

Arch Pharm Res. 2008 Apr;31(4):518-22. doi: 10.1007/s12272-001-1187-4. Epub 2008 May 1.

PMID:
18449511
14.

Influence of midazolam on pharmacokinetics of verapamil in rabbits.

Orszulak-Michalak D, Owczarek J, Wiktorowska-Owczarek AK.

Pol J Pharmacol. 2002 Sep-Oct;54(5):501-6.

15.

Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.

Mateus FH, Lepera JS, Marques MP, Boralli VB, Lanchote VL.

Can J Physiol Pharmacol. 2008 May;86(5):232-9. doi: 10.1139/y08-017.

PMID:
18432283
16.

Effect of naringin pretreatment on bioavailability of verapamil in rabbits.

Yeum CH, Choi JS.

Arch Pharm Res. 2006 Jan;29(1):102-7.

PMID:
16491851
17.

Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.

Choi DH, Chang KS, Hong SP, Choi JS, Han HK.

Biopharm Drug Dispos. 2008 Jan;29(1):45-50.

PMID:
17941000
18.

Effects of liver fibrosis on verapamil pharmacokinetics in rats.

Chen M, Xu D, Hu XL, Wang H.

Clin Exp Pharmacol Physiol. 2008 Mar;35(3):287-94. Epub 2007 Oct 31.

PMID:
17973928
20.

Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.

Busse D, Fromm MF, Mörike K, Drescher S, Kühlkamp V, Eichelbaum M.

Clin Pharmacol Ther. 2001 May;69(5):324-32.

PMID:
11372000

Supplemental Content

Support Center